The human NCX gene, a homologue of the murine neural crest homeobox ( Ncx / Hox11L.1 ) gene whose expression is restricted to a subset of neural crest -derived tissues, was expressed in human neuroblastoma cells but not in other tumors or fibroblasts. 
R egulated expression of a therapeutic gene in a target tissue increases the feasibility of gene therapy. Preferential expression of a suicide gene in tumor cells is particularly important for the safety and the efficacy of suicide gene therapy. 1, 2 A regulatory sequence of the gene whose expression is specific to a certain cell lineage enables the expression of a fused foreign gene restricted in the cell lineage. The use of a tissue -and stage -specific promoter is one of the approaches that permit selective expression of an exogenous gene in the tumors that develop from the specified cell lineage. Restricted expression of a suicide gene in tumors can avoid unnecessary adverse effects produced in surrounding normal tissues. 3 The murine Ncx /Hox11L.1 gene, which belongs to a Hox11 homeobox gene family, is located outside the clustered homeobox gene. 4 Although the function of this gene product remains unexplored, the expression of this gene is restricted to a certain neuronal subset of neural crest -derived tissues, such as dorsal root ganglia, intestinal ganglia, and adrenal gland in mice embryo, and intestinal ganglia and adrenal gland in adult mice. 5 The homozygous deletion of the Ncx /Hox11L.1 gene in mice showed hyperinnervation of the enteric neurons and megacolon developed thereafter. 6 Because the NCX gene, a human homologue of the Ncx /Hox11L.1 gene, 7 is highly conserved between two species not only in the coding region but in the 5 0 upstream region, expression of the NCX gene is also expected to be specific to a subset of neural crest -derived tissues.
Neuroblastoma is the most common extracranial solid tumor in children and is originated from the neural crest cells. Because the Ncx /Hox11L.1 gene is expressed in murine neuroblastoma cells, 7 a promoter region of the NCX gene could activate a fused foreign gene in human neuroblastoma cells. In this study, we examined whether a 5 0 upstream genomic fragment of the NCX gene contained a neuroblastoma -specific promoter region and the expression of the promoter-linked suicide gene was cytotoxic to neuroblastoma cells.
MATERIALS AND METHODS

Cells
Human neuroblastoma cell lines, SH -SY5Y, NGP, NMB, NBL -S, NLF, and SMS -SAN, and human melanoma A875 cells were kindly provided by Dr. A. Nakagawara ( Chiba Cancer Center, Chiba, Japan ) and Dr. G. M. Brodeur (Children's Hospital of Philadelphia, PA ). Human fibroblast cell lines, MRC -5 and CDC18Co, were from Japanese Cancer Research Resource Bank. All of the cell lines used were grown in RPMI1640 medium supplemented with 10% heat -inactivated fetal calf serum.
Northern blot analysis
Total RNA ( 20 g ) extracted from cultured cells were subjected to electrophoresis under a denaturing condition in an agarose -formaldehyde gel, and were transferred to a nylon membrane. The filter was hybridized with [ 32 P ]dCTP -labeled EcoRI /MluI fragment of the NCX cDNA 7 and the human glyceraldehyde 3 -phosphate dehydrogenase (GAPDH ) cDNA. Hybridization was performed in a solution of 50% formamide /5Â SSC / 50 mM NaH 2 PO4 /2Â Denhardt's solution /0.1% sodium dodecyl sulfate (SDS )/ 0.1 mg /mL salmon sperm DNA at 428C for 12 hours. The filter was washed with a solution of 0.2Â SSPE /0.1% SDS several times at 508C. A slot -blotted membrane (human multiple tissue expression array, Clontech, Palo Alto, CA ) that contained mRNA from 68 kinds of human tissues including various brain, gastrointestinal, urogenital, hematopoietic, vascular, and fetal tissues was also used.
Reporter gene assay
Transcriptional activity by 5 0 upstream regions of the NCX gene was measured with a dual -luciferase reporter assay system ( Promega, Madison, WI ). Genomic DNA fragments containing 4.5 -kb upstream of the NCX gene ( NCX4.5 ) were fused with the firefly luciferase gene in a reporter vector (pGL2 -basic, Promega). Sequentially deleted genomic fragments from the 5 0 side (NCX2.1, NCX1.7, NCX1.0, and NCX0.5 ) were created by digesting NCX4.5 DNA with restriction enzymes as illustrated in Figure 2 . Respective plasmid DNA was transfected into target cells with a control vector, the renilla luciferase gene fused with the HSV-TK promoter (pRL -TK ) ( Promega ), at a molar ratio of 10:1 with a lipofectin reagent ( Life Technologies, Gaithersburg, MD ). Two days later, cells were lysed and the luciferase activity was measured according to a manufacturer's protocol. Transfection efficiency was adjusted by the amounts of luminescence produced by the renilla luciferase gene and the relative luciferase activity of each cell lysate was expressed as a percentage of the SV40 immediate early promoter ( pGL2 -control, Promega )-mediated activity. All of the values were expressed as a mean of three independent experiments.
Sensitivity to ganciclovir ( GCV )
The CMV promoter in the pcDNA3 vector ( Invitrogen, San Diego, CA ) was replaced with the NCX1.7 promoter (NCX1.7 ) and then the HSV-TK gene was placed downstream to the promoter (NCX1.7-TK ). Cells were transfected with the NCX1.7 or NCX1.7-TK DNA using a lipofectin reagent and were selected with G418 ( 400 g/ mL ). G418 -resistant cells (1Â10 3 cells per well of 96 -well plates ) were incubated with various concentrations of GCV for 7 days and the viability of the treated cells was examined with a cell -counting kit ( Dojindo, Osaka, Japan ). Relative viability was calculated based on the viability of cells that were cultured without GCV.
RESULTS
Expression of the NCX gene
Northern blot analysis showed that all of the human neuroblastoma cell lines tested expressed the NCX gene but other human tumor cell lines, A875 (melanoma ), AsPC -1 ( pancreatic cancer ), and QG56 ( lung cancer ), or normal human fibroblast cell lines (HFF, MRC -5, and CDC18Co ) were negative for the expression ( Fig 1 ) . Because the NCX gene is highly homologous to other genes belonging to the HOX 11 family, several hybridized bands corresponding to other NCX -related genes were observed in human neuroblastoma cells. The expression in 68 different human normal tissues was undetectable by slot blot analysis (data not shown).
Transcriptional activation by 5 0 upstream regions of the NCX gene
We examined whether a 4.5 -kb genomic DNA fragment in the 5 0 -flanking upstream region of the NCX gene contained cis -acting regulatory element( s ) that could activate the transcription of the luciferase reporter gene. The luciferase activity showed that this genomic fragment transcribed the reporter gene in human neuroblastoma ( Fig 3A ) . The promoter activity by the 4.5 -kb fragment was stronger than that by the SV40 promoter. 
NARITA, BAHAR, HATANO, ET AL: NCX PROMOTER -MEDIATED HSV -TK EXPRESSION
To delineate the minimal promoter region of the NCX gene we examined the transcriptional activity by genomic fragments that were sequentially deleted from the 5 0 side ( Fig 2 ) . The luciferase activities demonstrated that transcriptional activities in neuroblastoma cells were retained with the fragments deleted up to À 1661 -bp from the translation initiation sites (NCX4.5, NCX2.1, and NCX1.7 ) but were significantly decreased with the fragments deleted further ( NCX1.0 and NCX0.5) ( Fig 3A ) . The promoter activity by the NCX1.7 DNA was also stronger than that by the SV40 promoter in neuroblastoma cells tested.
The same chimeric luciferase constructs were tested for their promoter activity in human normal fibroblast cell lines ( Fig 3B ) and non-neuroblastoma tumor cells (Fig 3C ) . The transcriptional activities by various NCX fragments tested in three kinds of fibroblasts varied but all of the constructs showed lower promoter activity compared with the SV40 promoter. The transcriptional activation mediated by respective NCX fragments was much lower than that by the SV40 promoter in NCX -negative tumors.
Improved sensitivity of neuroblastoma to GCV Neuroblastoma, NMB, and NGP cells, and pancreatic cancer AsPC -1 cells were transfected with either NCX1.7 DNA or NCX1.7-fused HSV-TK gene (NCX1.7-TK ) to examine whether the NCX promoter could activate the suicide gene and kill neuroblastoma cells. Respective G418 -resistant cells and parent cells were exposed to various concentrations of GCV (Fig 4) . The cytotoxicity to GCV was significantly increased in two neuroblastoma cell lines that were transfected with NCX1.7-TK DNA but not with NCX1.7 DNA ( Fig 4A and B ) . The sensitivity of NCX1.7 -transfected neuroblastoma cells was not increased compared with that of respective parent cells. In contrast, the sensitivity of AsPC -1 cells was not affected by the transfection of NCX1.7-TK DNA at all (Fig 4C ) .
DISCUSSION
A promoter region of the gene that is expressed in a certain cell lineage could confer selective expression of the promoter-fused exogenous gene in the lineage -derived cells. Tumors of the same lineage origin can also express the lineage -specific gene. In that case, selective cytotoxicity to the tumors should be achieved by the controlled expression of a suicide gene with such promoters. This strategy has been evidenced by osteocalcin 8 and thyroglobulin 9 promoters for osteosarcoma and thyroid tumors, respectively. Another approach is to use the regulatory sequences of oncofetal protein such as -fetoprotein and carcinoembryonic antigen to express foreign genes in hepatic tumors 10, 11 and tumors of the digestive tract, 12,13 respectively. Although the gene expression with the cell typespecific promoters is strictly regulated, the promoter activity could not be as strong as that with the promoters of oncofetal protein genes.
The murine Ncx / Hox11L.1 gene is restrictedly expressed in a neuronal subset but not in melanocytes or mesenchymal cells. 5 Because the 5 0 -flanking region of the Ncx gene is well conserved in the human homologue NCX gene, 7 the expression profile of the NCX gene is expected to be specific to the neuronal subset. The present study showed that the NCX gene was expressed in neuroblastoma but not in non -neuroblastoma cells or normal human tissues examined. Several hybridized signals detected in Northern blot analysis suggests the presence of the NCXrelated genes and /or its alternatively spliced transcripts as reported. 7 Precise analysis of the regulatory region of the Ncx gene showed that a 20 -bp fragment ( À 1387 / À 1368 from the translation initiation site ) was responsible for neuroblastoma -specific expression. 7 This region corresponds to the À 1506 / À 1487 fragment of the NCX gene and is localized within the neuroblastoma -specific promoter region ( À 1661 / À 1012 ) identified in the present study. The À 1506 / À 1487 sequence does not match with any of consensus binding sites for transcriptional factor( s), although a number of putative binding sites for transcription factor( s ) such as c -Myc 14 and GATA -1 15 are found in the À 1661 / À 1012 region.
The NCX1.7 promoter activity was much stronger than the SV40 promoter activity in neuroblastoma cell lines but was weaker than that in non-neuroblastoma cells. Differential promoter activity between NCX -positive neuroblastoma and NCX -negative cells was most extensively observed in the NCX1.7 promoter. The cytotoxic assays using GCV demonstrated that the NCX1.7 promoter could activate the transcription of the fused HSV-TK gene in NCX -positive neuroblastoma but not in NCX -negative cells. Antitumor effects in vivo by the NCX1.7 -TK /GCV system is, however, difficult to be examined at present, because these human neuroblastomas do not develop solid tumor in mice. Further analyses regarding the specificity of the NCX1.7 -kb promoter are also required to apply the promoter to clinical usage such as purging neuroblastoma cells from hematopoietic cells. 16 In this study, we showed that delineation of a promoter region of the gene whose expression was spatially and temporally specific to a certain cell lineage provided us a therapeutic strategy to activate a foreign gene in the lineage -derived tumors.
